AT-001 Uses, Dosage, Side Effects and more
AT-001 is under investigation in clinical trial NCT03062384 (AT-001 for Long-term Preservation of Brain Health in Aging).
Trade Name | AT-001 |
Generic | AT-001 |
Type | |
Formula | C17H10F3N5O3S |
Weight | Average: 421.35 Monoisotopic: 421.045644865 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |